.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
AstraZeneca
Cerilliant
Accenture
Julphar
Federal Trade Commission
Farmers Insurance
UBS
Argus Health
QuintilesIMS

Generated: December 14, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Italy Patent: MI96A0992

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Depomed IncCAMBIAdiclofenac potassiumFOR SOLUTION;ORAL022165-001Jun 17, 2009ABRXYesYes► Subscribe► Subscribe► SubscribeYYACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
Depomed IncCAMBIAdiclofenac potassiumFOR SOLUTION;ORAL022165-001Jun 17, 2009ABRXYesYes► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist